Allergen immunotherapy in allergic rhinitis: current use and future trends
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Allergen immunotherapy in allergic rhinitis: current use and future trends
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 13, Issue 9, Pages 897-906
Publisher
Informa UK Limited
Online
2017-05-23
DOI
10.1080/1744666x.2017.1333423
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unknown
- (2018) EUROPEAN JOURNAL OF IMMUNOLOGY
- Clinical use of adjuvants in allergen-immunotherapy
- (2017) Ludger Klimek et al. Expert Review of Clinical Immunology
- Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma
- (2016) J. Christian Virchow et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1–derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study
- (2016) François Spertini et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch
- (2016) Stacie M. Jones et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Unknown
- (2016) ALLERGY
- From IgE to clinical trials of allergic rhinitis
- (2015) Giorgio Ciprandi et al. Expert Review of Clinical Immunology
- Allergenspezifische Immuntherapie bei Rhinitis allergica
- (2015) L. Klimek et al. HNO
- Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
- (2015) Cezmi A Akdis et al. World Allergy Organization Journal
- Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper
- (2014) O. Pfaar et al. ALLERGY
- Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber
- (2013) W. Meyer et al. ALLERGY
- Immuntherapie der allergischen Rhinitis ohne Allergene?
- (2013) L. Klimek et al. HNO
- Grading local side effects of sublingual immunotherapy for respiratory allergy: Speaking the same language
- (2013) Giovanni Passalacqua et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen
- (2013) Piyush Patel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis
- (2013) Peter S. Creticos et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immunological effects and tolerability of a new fast updosed immunologically enhanced subcutaneous immunotherapy formulation with optimized allergen/adjuvant ratio
- (2012) O. Pfaar et al. ALLERGY
- An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergy
- (2012) C. Rask et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Adjuvants for immunotherapy
- (2012) Oliver Pfaar et al. Current Opinion in Allergy and Clinical Immunology
- Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections
- (2012) Gabriela Senti et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2
- (2012) Natalija Novak et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial
- (2012) Stephen R. Durham et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Perspectives on allergen-specific immunotherapy in childhood: An EAACI position statement
- (2012) M. A. Calderon et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Mechanisms of allergen-specific immunotherapy
- (2012) Hiroyuki Fujita et al. Clinical and Translational Allergy
- Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?
- (2011) G. Senti et al. ALLERGY
- Immunotherapy concepts under investigation
- (2011) T. M. Kündig ALLERGY
- Immunological mechanisms of sublingual allergen-specific immunotherapy
- (2011) N. Novak et al. ALLERGY
- A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy*
- (2011) O. Pfaar et al. ALLERGY
- European Academy of Allergy and Clinical Immunology task force report on ‘dose-response relationship in allergen-specific immunotherapy’
- (2011) M. A. Calderón et al. ALLERGY
- Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen
- (2011) Lawrence M. DuBuske et al. ALLERGY AND ASTHMA PROCEEDINGS
- Gram-positive bacteria on grass pollen exhibit adjuvant activity inducing inflammatory T cell responses
- (2011) B. Heydenreich et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Immunotherapy for allergic rhinitis
- (2011) S. M. Walker et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study
- (2011) L. Klimek et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Design and Recruitment for the GAP Trial, Investigating the Preventive Effect on Asthma Development of an SQ-Standardized Grass Allergy Immunotherapy Tablet in Children with Grass Pollen–Induced Allergic Rhinoconjunctivitis
- (2011) Erkka Valovirta et al. CLINICAL THERAPEUTICS
- CpG DNA as a vaccine adjuvant
- (2011) Christian Bode et al. Expert Review of Vaccines
- Novel Administration Routes for Allergen-Specific Immunotherapy: A Review of Intralymphatic and Epicutaneous Allergen-Specific Immunotherapy
- (2011) Seraina von Moos et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Adjuvants and Vector Systems for Allergy Vaccines
- (2011) Philippe Moingeon et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy
- (2011) Margitta Worm et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study
- (2011) Gabriela Senti et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- GA2LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma
- (2010) T. Zuberbier et al. ALLERGY
- Efficacy and Safety of a Glutaraldehyde-Modified House Dust Mite Extract in Allergic Rhinitis
- (2010) Herbert Riechelmann et al. American Journal of Rhinology & Allergy
- Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI Collaborative Study
- (2010) David I. Bernstein et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials
- (2010) Gabriela Senti et al. Current Opinion in Allergy and Clinical Immunology
- Designing CD8+ T cell vaccines: it's not rocket science (yet)
- (2010) Jonathan W Yewdell CURRENT OPINION IN IMMUNOLOGY
- Sublingual Allergen-Specific Immunotherapy Adjuvanted with Monophosphoryl Lipid A: A Phase I/IIa Study
- (2010) Oliver Pfaar et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System
- (2010) Linda Cox et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: A randomized controlled trial
- (2010) Stefan Zielen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study
- (2009) H. Ott et al. ALLERGY
- Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial
- (2009) G. Senti et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy
- (2009) Gabriela Senti et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber
- (2009) Friedrich Horak et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Viral Sequestration of Antigen Subverts Cross Presentation to CD8+ T Cells
- (2009) Eric F. Tewalt et al. PLoS Pathogens
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
- (2008) J. Bousquet et al. ALLERGY
- The coming of age of virus-like particle vaccines
- (2008) Gary T. Jennings et al. BIOLOGICAL CHEMISTRY
- The European Union CREATE Project: A model for international standardization of allergy diagnostics and vaccines
- (2008) Martin D. Chapman et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis
- (2008) Gabrielle Pauli et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
- (2008) G. Senti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells
- (2007) Jean-Pierre Allam et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood
- (2007) Bengt Björkstén et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started